Search results
Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering , in Cambridge, England.
Oct 3, 2018 · Sir Gregory Winter, awarded the #NobelPrize in Chemistry, has used phage display to produce new pharmaceuticals. Today phage display has produced antibodies that can neutralise toxins, counteract autoimmune diseases and cure metastatic cancer.
May 10, 2024 · Gregory P. Winter, British biochemist known for his development of the first humanized antibodies, his research on directed antibody evolution, and his application of phage display technology for the development of fully human therapeutic antibodies.
- Kara Rogers
Photo: A. Mahmoud. Sir Gregory P. Winter The Nobel Prize in Chemistry 2018. Born: 14 April 1951, Leicester, United Kingdom. Affiliation at the time of the award: MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. Prize motivation: “for the phage display of peptides and antibodies”.
Sir Gregory Winter, Research Leader Emeritus at the MRC Laboratory of Molecular Biology (LMB) in Cambridge, UK is best known for his pioneering work on humanised and human therapeutic antibodies. Greg’s research career has been entirely based in Cambridge.
Oct 7, 2019 · Volume 286, Issue 19. October 2019. Pages 3742-3744. Sir Gregory Winter, Research Leader Emeritus at the MRC Laboratory of Molecular Biology (LMB) in Cambridge, UK is best known for his pioneering work on humanised and human therapeutic antibodies.
Interview with Chemistry Laureate Sir Gregory P. Winter on 6 December 2018 during the Nobel Week in Stockholm, Sweden. Read the interview.
